Advertisement
Europe
Subscribe to Europe

The Lead

EMA Reports Vials of Falsified Herceptin Identified

April 16, 2014 8:41 am | News | Comments

The European Medicines Agency (EMA) has been informed that vials of the cancer medicine Herceptin (trastuzumab), thought to have been stolen in Italy, including from hospitals, have been tampered with and re-introduced under false credentials into the supply chain in some countries.

BioAlliance Pharma and Topotarget Announce Merger Agreement

April 16, 2014 8:22 am | News | Comments

BioAlliance Pharma SA and Topotarget A/S today announced their intention to merge to create an...

Report: Glaxo Bribed Doctors in Poland

April 14, 2014 9:25 am | News | Comments

The BBC reports that pharmaceutical company GlaxoSmithKline is accused of bribing doctors to...

Moberg Pharma Acquires Rights to Topical Formulation for Treatment of Oral Pain

April 14, 2014 7:58 am | News | Comments

Moberg Pharma AB has entered into a definitive agreement with Oracain II Aps (Denmark) to...

View Sample

FREE Email Newsletter

Meda Turns Down Mylan

April 4, 2014 10:57 am | News | Comments

Swedish drug company Meda has rebuffed an approach from generic drug maker Mylan which was looking to combine the two businesses. Meda AB says talks between the two companies have stopped "without further actions."          

FDA OKs First Hay Fever Allergy Immunotherapy Tablet

April 2, 2014 11:28 am | by The Associated Press | News | Comments

The U.S. Food and Drug Administration has approved the first tablet for gradually reducing hay fever allergy symptoms, an alternative to uncomfortable allergy-desensitizing shots.            

Evotec and Debiopharm Group to Develop Cancer Treatment

April 2, 2014 8:47 am | News | Comments

Evotec AG has announced a research collaboration and licensing deal with Debiopharm Group Lausanne, Switzerland. The objective of this collaboration is to identify and develop novel compounds having the potential to treat multiple forms of solid tumors and leukemias with defined genetic alterations.

Advertisement

Evotec and Convergence Form Integrated Pain Alliance

March 31, 2014 9:02 am | News | Comments

Evotec AG today announced that it has entered into a research alliance with Panion Ltd, a subsidiary of Convergence Pharmaceuticals Holdings Ltd. Convergence is a UK company focused on the development of novel, high value analgesics to treat chronic pain.

Britain: Two People Catch TB from Pet Cat

March 28, 2014 8:18 am | News | Comments

England's public health agency says two people have caught tuberculosis from a pet cat, the first time the bacterial disease has been documented to spread from cat to human.             

Endocyte Surges on News for Cancer Drug

March 24, 2014 8:16 am | News | Comments

Shares of Endocyte nearly doubled in value Friday after European Union regulators said the company's drug Vynfinit should be approved as a treatment for ovarian cancer.              

U.S. Pharmaceutical Company to Move HQ to Ireland

March 21, 2014 8:32 am | Videos | Comments

Horizon Pharma Inc. will acquire Vidara Therapeutics for a "tax-efficient corporate structure."                          

Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences

March 14, 2014 8:38 am | News | Comments

Idenix Pharmaceuticals has filed patent infringement lawsuits against Gilead Sciences and/or certain of its subsidiaries in each of three countries - France, Germany and the United Kingdom.           

Advertisement

Intrexon Acquires Lab Operations from Codexis

March 14, 2014 8:09 am | News | Comments

Intrexon Corporation, a synthetic biology company,  has acquired state-of-the-art laboratory operations in Budapest, Hungary from Codexis, Inc., a developer of biocatalysts for the pharmaceutical and complex chemistry industries.    

Chiesi Group Reports Double-Digit Growth and International Expansion

March 13, 2014 8:04 am | News | Comments

Chiesi Farmaceutici SpA, an international pharmaceutical company focused in the respiratory, neonatology and special care therapeutic areas, closed 2013 with a turnover of more than 1,236 million euro, an increase of 11.8% compared to 2012 (+14% at constant exchange rates).

AstraZeneca to Sell Alderley Park Site in Cheshire, UK

March 12, 2014 8:03 am | News | Comments

AstraZeneca today announced the sale of its Alderley Park site in Cheshire, UK, to Manchester Science Parks (MSP), a Greater Manchester based public-private partnership and science park operator.         

Alexion Shares Rise after Company Raises 2014 Guidance

March 10, 2014 1:29 pm | News | Comments

Alexion Pharmaceuticals raised its 2014 guidance on Monday, saying the national health agency of France will reimburse it for past sales of its drug Soliris.                

EMA PRAC Recommends Restricting Use of Domperidone

March 7, 2014 8:31 am | News | Comments

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has completed a review of domperidone-containing medicines and has recommended changes to their use throughout the European Union (EU).      

Advertisement

Endo Appoints New Chief Scientific Officer and Global Head of R&D and Quality

March 7, 2014 8:04 am | News | Comments

Endo International has appointed Susan Hall, Ph.D. as executive vice president, chief scientific officer and global head of research & development and quality, effective March 10, 2014.           

PROVENGE® to be Commercially Available in Europe

March 3, 2014 8:03 am | News | Comments

Dendreon Corporation today announced that it plans to make PROVENGE ® (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) available in Europe, beginning with Germany and the United Kingdom.    

European Medicines Agency Recommends that Protelos/Osseor Remain Available But with Further Restrictions

February 21, 2014 8:23 am | News | Comments

The European Medicines Agency has concluded its review of Protelos/Osseor and has recommended further restricting the use of the medicine to patients who cannot be treated with other medicines approved for osteoporosis.      

UCB Announces CEO Succession Plan

February 20, 2014 8:14 am | News | Comments

Jean-Christophe Tellier, currently UCB’s Executive Vice President, Biopharma Brands and Solutions, will be appointed Chief Executive Officer-Elect and Chairman of the Executive Committee as of March 1, 2014. Jean-Christophe Tellier will also be proposed to be appointed as a member of the Board of Directors at the next Annual General Meeting of Shareholders on April 24, 2014.

Europe at Origin of Chronic US Execution Dilemma

February 18, 2014 5:11 am | by Juergen Baetz - Associated Press - Associated Press | News | Comments

There's one big reason why the United States has a dearth of execution drugs so acute that some states are considering solutions such as firing squads and gas chambers: Europe's fierce hostility to capital punishment. The phenomenon started nine years ago when the EU banned the export of products used for execution, citing its goal to be the "leading institutional actor and largest donor to the fight against the death penalty."

Cancer Experts Say EU Rules Deny Kids Medicines

February 11, 2014 7:27 am | by MARIA CHENG, AP Medical Writer | News | Comments

Leading cancer experts say Europe's antiquated drug regulatory system is stopping children from getting life-saving medicines and are calling for changes that would remove a loophole that allows companies to skip developing medicines for children already approved for adults.

Nestle Buying Out Galderma from L'Oreal

February 11, 2014 7:22 am | News | Comments

Swiss food and drink giant Nestlé and French cosmetics company L'Oréal have approved a deal to transfer ownership of Swiss dermatology pharmaceuticals company Galderma.              

UPS Closes on Purchase of Polar Speed

February 11, 2014 7:17 am | News | Comments

UPS said Tuesday that it has completed its acquisition of Polar Speed, a company that helps deliver temperature-sensitive pharmaceutical supplies in the United Kingdom. Financial terms were not disclosed.        

Jazz Pharmaceuticals Breaks Ground On New Manufacturing and Development Facility in Ireland

February 10, 2014 8:15 am | News | Comments

Jazz Pharmaceuticals  today announced that it has commenced construction of a manufacturing and development facility to be located on a 17-acre site in Monksland, County Roscommon, approximately 75 miles east of the company's Dublin headquarters. This is the first manufacturing facility to be built by Jazz Pharmaceuticals.

XIGDUO™ Approved in the European Union for Type 2 Diabetes

January 22, 2014 8:06 am | News | Comments

AstraZeneca and Bristol-Myers Squibb today announced that Xigduo™ (dapagliflozin and metformin hydrochloride in 5mg/850mg and 5mg/1000mg tablets) has been granted Marketing Authorization by the European Commission for the treatment of type 2 diabetes in the European Union (EU).

France OKs Sales of Medicine Derived from Cannabis

January 9, 2014 8:07 am | News | Comments

France's Health Ministry said that sales of Sativex, produced by Britain's GW Pharmaceuticals, will be allowed for the treatment of muscle spasms associated with multiple sclerosis.           

German Firm Appeals Spanish Thalidomide Ruling

December 20, 2013 1:34 pm | News | Comments

A German pharmaceutical company says it is appealing a Spanish court ruling ordering it to pay compensation to 22 Spaniards who blame their disabilities on the drug thalidomide.           

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading